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ABSTRACT
The cytokine TSLP was originally identified in a murine thymic stromal cell line as a lymphoid growth factor. Af-
ter the discovery of TSLP, extensive molecular genetic analyses and gene targeting experiments have demon-
strated that TSLP plays an essential role in allergic diseases. In this review, we discuss the current status of
TSLP and its functional role in allergic diseases particularly by focusing on effects of TSLP on haematopoietic
cells in mouse models. It is our conclusion that a number of research areas, i.e., a new source of TSLP, effects
of TSLP on non-haematopoietic and haematopoietic cells, synergistic interactions of cytokines including IL-25
and IL-33 and a regulation of TSLP expression and its function, are critically needed to understand the whole
picture of TSLP involvement in allergic diseases. The mouse models will thus contribute further to our under-
standing of TSLP involvement in allergic diseases and development of therapeutic measures for human allergic
diseases.
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INTRODUCTION
Epithelial cells in skin, lung, nasal cavity and gut are
responsible for the first line of defense against for-
eign antigens and microbes. Epithelial cell-derived
cytokines and chemokines that are secreted in re-
sponse to infection and antigen exposure act on resi-
dent and circulating leukocytes and lead to subse-
quent immune response. In allergic diseases, i.e.,
atopic dermatitis (AD), asthma, allergic rhinitis and
food allergy, epithelial cells produce cytokines includ-
ing thymic stromal lymphopoietin (TSLP), IL-25 and
IL-33. Allergic diseases share a common pathogene-
sis involving overproduction of T helper 2 (Th2)-
cytokines (IL-4, IL-13 and IL-5) and elevated IgE.
Epithelial-derived allergic-inflammatory cytokines,
i.e., TSLP, IL-25 and IL-33, are strongly associated
with Th2 cytokines: TSLP indirectly and directly in-
duces differentiation of Th2 cells1-3; IL-25 also primes
CD4+ T cells into Th2 cells and acts on epithelial cells
to express TSLP4,5; IL-33 enhances Th2 cytokine se-
cretions in Th2-polarized cells.6 Mainly produced by
Th2 cells, pro-allergic Th2 cytokines induce B cells to
produce IgE. Since mechanisms for immune cas-
cades involving known factors in allergic diseases
have not been fully understood, our present review
will focus on TSLP and describe how TSLP plays a
role in allergic diseases of mouse models through im-
mune cascades.
INITIAL CHARACTERIZATION OF TSLP
The cytokine TSLP was originally identified in 1994
as a biologically active factor from the conditioned
medium of a murine thymic stromal cell line
Z210R.1.7 Since the conditioned medium used for the
discovery of TSLP supported the proliferation of pre-
B cell line NAG87, it was suspected that TSLP might
be one of factors for B cell development. It was then
reported that severe B and T cell lymphopenia oc-
curred in the periphery of IL-7 receptor (IL-7Rα and
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common-γ)- and IL-7-deficient mice.8-11 In this lym-
phopenia, B cell development was blocked at a transi-
tion from pre-pro-B to pro-B cells in bone marrow of
IL-7R-deficient mice.8-10 In IL-7-deficient mice, on the
other hand, a transition from pro-B to pre-B cells was
blocked.11 Although the absolute cell number had de-
creased in IL-7-deficient mice, mature B cells still ex-
isted in the periphery, indicating that an unknown cy-
tokine could drive B cell differentiation.8-11
One of the candidates for this unknown cytokine is
actually TSLP. Since TSLP uses IL-7Rα subunit, shar-
ing with the IL-7R complex, it was thought that the
biological characteristics of TSLP, i.e., lymphopoietic
activity, overlapped with IL-7. When precursors from
either fetal liver or adult bone marrow were cultured
in the presence of either TSLP or IL-7, TSLP was
shown to promote the development of B220+IgM+
immature B cells whereas IL-7 facilitated the develop-
ment of B220+IgM− pre-B cells.7,12 Taken together,
since development of B cell precursors was blocked
at different stages in IL-7Rα-deficient and in IL-7-
deficient mice, it was strongly suggested that TSLP
might utilize a unique TSLP-receptor (TSLPR) in
combination with IL-7Rα chain.12 Actual characteriza-
tion of TSLP and its receptor began when molecular
genetic analyses and gene targeting experiments
started in mice.
TSLP AS A POTENTIAL KEY PLAYER FOR
ALLERGIC DISEASES
cDNA clones expressing TSLP13 and its receptor14
were obtained by using expression cloning tech-
niques whereas human sequences of TSLP and its re-
ceptor were identified in silico methods.15 Since then,
a variety of approaches have been made to determine
TSLP function. In vitro studies using a recombinant
TSLP protein showed enhanced IL-1-induced prolif-
eration of CD4−CD8− thymocytes, whereas TSLP
alone had minimal activity.13 Furthermore, TSLP was
shown to promote B cell development in bone mar-
row cultures.12
Several TSLP-expressing transgenic mouse lines
have been generated. Mice expressing TSLP under
the control of the lck-proximal promoter preferentially
acting early in thymocyte development and subse-
quently in T cells were generated. These mice dis-
played abnormal thymic structure and contracted a
systemic inflammatory disease involving the kidney,
liver, spleen, lungs, skin and mixed cryoglobulin for-
mation.16 TSLP transgenic (Tg) mice under the con-
trol of ubiquitous β-actin composite promoter devel-
oped unbalanced lymphopoiesis and myelopoiesis,
and 40 to 80% of the mice died prematurely.17 In
these Tg mice, the dramatic increase in serum IL-5
levels was observed, suggesting that TSLP involve-
ment might be in pro-allergic immune responses.17
Interestingly, Soumelis et al. showed that, in humans,
TSLP-activated dendritic cells (DCs) primed naïve
CD4+ T cells into Th2 cells that secreted IL-4, IL-13
and IL-5.18 In addition, TSLP expression was signifi-
cantly elevated in the epidermis of lesional skin from
both acute and chronic AD patients.18 These results
all suggested that TSLP could be a potential key
player for allergic diseases in mice and humans.
Since Soumelis et al. made their report, a series of
studies using mouse models has focused on effects of
TSLP in allergic diseases. A crucial role of TSLP in
the development of AD and allergic asthma became
also evident when Tg mouse lines were used. Since
TSLP is expressed primarily by epithelial cells,18 a
number of Tg mouse lines have been generated to
determine effects of TSLP in allergic diseases: induc-
ible keratin 5 (K5)-19 and constitutive K14-20,21 TSLP
Tg mice for AD where TSLP is specifically expressed
in the epidermis; constitutive surfactant protein C
(SPC)-TSLP Tg mice22 for allergic airway inflamma-
tion where TSLP is specifically expressed in the lung
epithelial cells. The studies using these Tg mice
showed that the expression of TSLP both in the skin
and in the lung resulted in development of a sponta-
neous inflammation with the hallmark feature of AD
and allergic airway inflammation, respectively. There-
fore, TSLP mouse models to trace allergic symptoms
have now become the major research tool for allergic
diseases, despite the poor homology (43%) of amino
acids of TSLP between mice and humans.15
INDUCTION OF TSLP BY EXOGENOUS
FACTORS
To investigate the involvement of TSLP in non-
transgenic allergic disease models, three types of
models have been used: (1) antigen-driven models
using ovalbumin (OVA), (2) a protease model and (3)
a model of Th2-type contact hypersensitivity. In the
OVA-induced airway inflammation model, increased
levels of TSLP were observed, whereas TSLPR-
deficient mice displayed reduced airway inflammation
and goblet cell hyperplasia.22,23 Epicutaneous immu-
nization of mice with OVA induced allergic skin in-
flammation including skin infiltration of eosinophils,
increased levels of Th2 cytokines in the skin and
OVA-specific serum IgE, all of which significantly de-
creased in TSLPR-deficient mice.24 OVA-induced al-
lergic diarrhea accompanied by Th2 cytokine produc-
tion in gastrointestinal tract was also TSLP-TSLPR
signal-dependent.25 Finally, in OVA-induced allergic
rhinitis, treatment with a neutralizing anti-TSLP anti-
body decreased its symptoms26 (Fig. 1).
A recent study has reported that mechanical injury
in the skin induced temporary TSLP expression.27 In
the presence of OVA antigen, DCs isolated from the
skin of wild-type mice after mechanical injury elicited
increase in IL-4 and IL-13 productions in CD4+ T cells
with OVA-specific T cell receptor, whereas DCs from
the injured skin of TSLPR-deficient mice or from the
skin of un-injured mice induced the production of
TSLP and Allergy in Mice
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Fig.　1　Inducing factors and sources of TSLP in mice. Epithelial cells (airway epithelial cells, epidermal keratino-
cytes, intestinal epithelial cells and nasal epithelial cells), basophils and DCs are all capable of producing TSLP 
in the presence of exogenous and endogenous factors in mice. Note that epidermal keratinocyte-specifi c
RXRαβ-defi cient mice express TSLP (reference 20).
Inducing factors Sources References
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Epithelial cells 22, 23, 24, 25, 26
29, 30, 31
20, 34
20, 34
35, 36
39
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Basophils
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Protease allergen
(papain)
Protease allergen
(papain)
Fungal components
(TLR2/6-ligand)
Bacterial components
(TLR4-ligand)
Viral/bacterial components
(TLR9-ligand)
RXR/RARγ + ligand
RXR/VDR + ligand
Notch (-)
LEKTI (-)
IgE
Tissue damage
Biochemical components
(i.e., dibutyl phthalate)
Baso
Baso
DC
DC
DC
Protein allergen
(OVA)
both the cytokines at a relatively smaller amount.27
The study suggests that a protein antigen such as
OVA raises TSLP expression and that an increased
level of TSLP even temporarily in the skin by me-
chanical injury enhances antigen-derived Th2 re-
sponses by skin DCs (Fig. 1).
In addition to OVA, proteases also act as allergens.
For instance, a cysteine protease papain was shown
to induce the expression of Tslp in the injected site of
the skin in wild-type mice (Fig. 1). This expression of
Tslp was dependent on reactive oxygen species
(ROS), toll-like receptor (TLR) 4 and the adaptor pro-
tein TIR-domain-containing adaptor-inducing inter-
feron-β (TRIF).28
TSLP was induced in an experimental model of
Th2-type contact hypersensitivity, using FITC as an
allergen (a model for human Th2-type contact hyper-
sensitivity).29-31 A component of the solvent used in
this model, dibutyl phthalate, was shown to induce
TSLP expression29-31 (Fig. 1). In the absence of TSLP
responses, there was a profound decrease in type-2
immune responses in the skin and in antigen-bearing
DCs in the draining lymph node following FITC treat-
ment, and the DCs that did migrate displayed a de-
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creased capacity for promoting CD4+ T cell prolifera-
tion.29 All of the reports demonstrate that the factors
including OVA, proteases and dibutyl phthalate act as
inducing agents of TSLP and that TSLP is necessary
and sufficient for allergic inflammation in mice.
INDUCTION OF TSLP BY ENDOGENOUS
FACTORS
It has become also clear that mutations affecting skin
function can alter the expression of Tslp and lead to
inflammation. The keratinocyte-specific inducible ab-
lation of retinoid X receptors (RXRα and RXRβ) in
adult mice resulted in TSLP-dependent spontaneous
dermatitis with reddening, swelling and scaling20
(Fig. 1). In the inflamed skin of RXRαβ-deficient
mice, Th2-type cytokine expression and leukocyte in-
filtration consisting of CD4+ T cells, DCs, eosinophils
and mast cells were observed.20 RXRs belong to the
nuclear receptor (NR) superfamily and function by
forming either a homodimer or heterodimers with
partners such as vitamin D receptor (VDR), retinoic
acid receptor (RAR) family and PPARβ.32 Since het-
erodimers of RXRNR regulate transcriptions of tar-
get genes,33 the release of RXRNR mediated-
transcriptional repression could explain an elevated
expression of TSLP in epidermal keratinocyte-specific
RXRαβ-deficient mice. In their followup study, Li and
colleagues identified the NR partners of RXRα and -β
for the induction of TSLP. Among the agonists of
RXR partners, topical application of the agonistic
ligand for vitamin D3 and RARγ-selective ligand on
ear skin induced TSLP expression in epidermal
keratinocytes34 (Fig. 1). The results suggested that
the ligation of RXRVDR and RXRRARγ with those
ligands induced the expression of Tslp.
Epidermal-specific mutations in the Notch pathway
(Notch1, Notch2, or RBP-j, DNA binding partner of
Notch) resulted in a severe form of AD and B-
lymphoproliferative and myeloproliferative disorder
via TSLP-TSLPR signaling35,36 (Fig. 1). Notch signal-
ing contributes to terminal differentiation of keratino-
cytes in skin.37 The skin of AD patients showed mark-
edly reduced Notch expression in epidermis, imply-
ing a possible link between a downregulation of the
Notch signal and development of AD through
upregulation of TSLP.36
The involvement of nuclear factor κB (NFκB) sig-
naling in TSLP expression by mouse intestinal epithe-
lial cells38 implicates a possibility that NFκB may be
involved in TSLP expression in allergic inflamma-
tions. Mice lacking the multi-domain serine protease
inhibitor Spink5 expressed TSLP in the epidermis
along with proinflammatory and Th2-polarizing mole-
cules. Spink5, mutated in individuals as human Neth-
erton syndrome, dysregulates epidermal proteases
such as Kallikrein 5 (KLK5). In mice, a lack of Spink5
product (lymphoepithelial Kazal-type-related inhibitor
(LEKTI)) resulted in expressions of protease-
activated receptor 2 (PAR-2) and TSLP and mRNA of
F2rl1, Tslp and Tnf (Fig. 1).39 In addition, protease ac-
tivation of PAR-2 inducing expression of TSLP has
been observed in a number of settings using the hu-
man bronchial epithelial cell line BEAS-2B.40 Since
TNFα induces TSLP expression in intestinal epithe-
lial cells and because NFκB mediated the TSLP ex-
pression by TNFα,38 the induction of TSLP expres-
sion by TNFα andor PAR2 may possibly be medi-
ated by NFκB signaling in Spink5 deficient mice. In
fact, human TSLP expression in keratinocytes was
downregulated in the presence of an inhibitor for
NFκB pathway.39 Taken together, a wide variety of
endogenous factors were found to induce TSLP ex-
pression and subsequent Th2-type inflammation. Our
challenge will be to elucidate signaling pathways in-
volved in each of the endogenous factor in allergic
diseases.
EFFECTS OF TSLP ON LEUCOCYTES
TSLP signals cells via a TSLPR-IL-7Rα heterodi-
mer.14,41 TSLP-TSLPR signaling activates STAT5 in
mice but STAT1 and 5 and possibly STAT3, 4 and 6 in
humans.3,42,43 TSLP-mediated phosphorylation of
STAT5 was induced via JAK1 and JAK2 in mouse
CD4+ T cells whereas IL-7 signals through JAK1 and
JAK3 to activate STAT5.43 Several bone marrow-
derived cells, i.e., DCs, CD4+ T cells, CD8+ T cells,
NKT cells, early B cell precursors and basophil pro-
genitors, are capable of responding to TSLP.
As studied extensively in humans, DCs are likely to
be the primary target of TSLP in mice. When they
were exposed to TSLP, mouse and human DCs in-
creased the cell surface expressions of CD40, CD80,
CD86 and MHC class II18,22,23 (Fig. 2). These TSLP-
activated DCs enhanced antigen-mediated prolifera-
tion of CD4+ T cells.23 Furthermore, OX40L was ex-
pressed in OVA antigen-captured DCs in mediastinal
lymph node of the mice administered with OVA plus
TSLP, but not in OVA-uncaptured DCs.44 In addition,
in vivo blockade of OX40L with a specific antibody in-
hibited TSLP-driven Th2-type inflammation.44 Since
OX40L is expressed on professional antigen-
presenting cells including DCs and because activated
CD4+ and CD8+ T cells and most memory T cells dis-
play the receptor, OX40,45 it is suggested that in re-
sponse to TSLP, DCs may become activated and initi-
ate T cell-mediated Th2-type inflammation via OX40L
as reported in humans.3
CD4+ and CD8+ T cells are also capable of respond-
ing to TSLP (Fig. 2). Resting mouse CD4+ and CD8+
T cells expressed TSLPR and IL-7Rα at similar levels,
whereas human unactivated CD4+ and CD8+ T cells
did not express TSLPR.46 During Th2 differentiation
in mice, the expression of Tslpr and Il7ra subunits
was once downregulated after TCR-stimulation and
then was gradually upregulated (M.O.-M. unpub-
lished data) at a higher level in differentiated effector
TSLP and Allergy in Mice
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Fig.　2　Target cell populations of TSLP in mice. Dendritic cells, activated CD4+ T cells, differentiated CD4+ Th2 
cells, activated CD8+ T cells, activated NKT cells, pro-B cells, basophil-precursors and fi brocytes are all respon-
sive to TSLP.
TSLP
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express TSLPR Events References
Dendritic cells 22, 23MHC II⇧, CD40⇧, CD80⇧, CD86⇧,CCL17⇧
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Th2 differentiation (IL-4⇧, IL-5⇧, IL-13⇧)
IL-13 production⇧
Expansion⇧
Expansion of mature basophils
IL33R⇧,
IL-4⇧, IL-6⇧,
Cxcl2⇧, CCL3⇧, CCL4, CCL12⇧
Survival⇧
CD4+ T cells 24, 47, 48, 49
CD8+ T cells 46
NKT cells 51
Pro-B cells 52
53
64
Basophil
precursors
Fibrocytes Collagen production⇧
Baso
pre
DC
CD4T
CD8T
NKT
Pro
B
Th2 cells than in other Th subsets.47 TSLP directly
drove highly purified naïve CD4+ T cells into Th2
cytokine-secreting cells, an event that was not ob-
served in TSLPR-deficient CD4+ T cells.48 This direct
effect of TSLP on CD4+ T cells agrees with two other
reports: TSLP amplified Th2 cytokine secretion by
engaging TSLPR on antigen-specific mouse CD4+ T
cells but not on DCs in vitro24; TSLP induced the
phosphorylation of STAT5 in anti-CD3- plus anti-
CD28-activated human CD4+ T cells.43 In addition,
TSLP was capable of both enhancing proliferation of
anti-CD3-activated CD4+ T cells and differentiated ef-
fector Th2 cells47,49 and promoting the survival of
both CD4+ and CD8+ T cells.46,49 These studies sug-
gest that TSLP preferentially expands Th2-type CD4+
T cells and contributes to both CD4+ and CD8+ T cell
homeostasis.
In development of allergic asthma, activation of
NKT cells is critically involved.50 NKT cells ex-
pressed both TSLPR and IL-7Rα, and anti-CD3-
activated NKT cells produced IL-13 in the presence of
TSLP (Fig. 2). In SPC-TSLP Tg mice with elevated
levels of lung-specific TSLP, a lack of NKT cells re-
sulted in reduced airway hyperresponsiveness after
an antigen challenge.51 These results suggest that IL-
13 produced by TSLP-stimulated NKT cells could ag-
gravate asthmatic symptoms.
As described above, TSLP was initially described to
be a B cell growth and differentiation factor. Subse-
quent in vivo studies have supported these results.
K5-TSLP Tg mice expressing an inducible TSLP
transgene in the epidermis displayed highly circulat-
ing levels of TSLP when they were treated with doxy-
cycline.52 These mice showed (1) an influx of imma-
ture B cells from bone marrow into the periphery, (2)
a population expansion of follicular mature B cells
and peritoneal B-1b cells and (3) a loss of marginal
zone B cells. Among developmental subsets of B
cells, pre-pro-B cells and pro-B cells expressed both
TSLPR and IL-7Rα. The pro-B cells were expanded in
the presence of TSLP (Fig. 2). The analysis of K5-
TSLP Tg mice as well as in vitro studies identified
late pro-B cells as a key TSLP-responsive subset and
the effect of TSLP led to developmental abnormalities
of B cells.52 Although one study showed that human
B cells expressed neither TSLPR nor IL-7Rα,15 TSLP
Omori-Miyake M et al.
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promoted the differentiation of CD19+VpreB+ pre-B
cells that were derived from CD34+ human cord
blood progenitors.52
Recently, TSLP was discovered to promote baso-
phil haematopoiesis from bone marrow resident pre-
cursors. In fact, SPC-TSLP Tg mice have elevated ba-
sophil numbers and TSLP was shown to promote ba-
sophils differentiation from precursors in the bone
marrow in the absence of IL-3-IL-3R signaling.53 In ad-
dition, basophils contributed to Th2 responses by
supplying Th2 cytokines and presenting antigens to
CD4+ T cells.54-56 Moreover, TSLP-elicited basophils
expressed IL-33R at relatively higher level than IL-3-
elicited basophils53 (Fig. 2). Once basophils were ex-
panded in a TSLP-dominant allergic environment,
they could play a key role in the development of aller-
gic symptoms by producing a Th2 cytokine IL-4 and
increasing a susceptibility to IL-33 (another allergy-
associated cytokine). Since there was only one report
on effects of TSLP on basophil haematopoiesis, more
studies will be needed to examine interactions of ba-
sophils with TSLP and IL-33.
THE ATOPIC MARCH AND TSLP
Atopic diseases including AD, asthma, and allergic
rhinitis share common features such as overproduc-
tion of Th2-cytokines leading to eosinophilia and IgE-
mediated responses to allergens. Since children with
AD tend to develop allergic asthma later in life and
because severity of eczema of AD is associated with
sensitivity to asthma and allergic rhinitis, AD is the
major risk factor for developing other atopic dis-
eases.57,58 Recently, a role of TSLP as a potential fac-
tor linking to the atopic march has been investigated.
As observed in mice treated with a vitamin D3 analog
or in the skin of K14-TSLP Tg mice, TSLP that was
highly expressed in epidermis aggravated the allergic
responses in the lung that were induced by OVA.59,60
These mice displayed a very high level of circulating
TSLP. Similar results were also obtained in K5-TSLP
Tg mice (S.F.Z. and H. Han, manuscript in prepara-
tion). The above results suggest that elevated circu-
lating TSLP plays a confounding role in these studies.
This conclusion is supported in part by a recent study
of Zhu and colleagues.61 In this report, mice with
epidermal-specific expression of IL-13 developed AD
and showed enhanced airway inflammation following
allergen challenge. Interestingly, these mice also
showed elevated TSLP expression in the skin, but cir-
culating TSLP was barely detectable. This lung in-
flammation was reduced in TSLPR-deficient environ-
ment,61 suggesting that IL-13-mediated local expres-
sion of TSLP in the skin may be critical to sensitize
the lung to allergen challenge. Although all these re-
ports clearly demonstrate an important role of TSLP
in the atopic march, a role of circulating TSLP in dif-
ferent settings of the atopic march remains to be in-
vestigated.
CONCLUSIONS
The present review of TSLP in mouse models pro-
vides the current status of TSLP and its functional
role in allergic diseases, particularly by focusing on
the effects of TSLP on haematopoietic cells. As clini-
cal trials using TSLP neutralizing antibodies are cur-
rently underway, the mouse models described in this
review will be an invaluable complement to the hu-
man clinical studies. However, several areas of re-
search on TSLP will be needed to have a better un-
derstanding of the underlying mechanisms for devel-
opment of allergic diseases. A new source of TSLP
should be explored, since it was reported that human
monocyte-derived and mouse bone marrow-derived
DCs actually produced TSLP in the presence of a
ligand for TLR26, -4 or -962 and that mouse basophils
expressed Tslp in response to active papain or IgE
crosslinking63 (Fig. 1). Studies of effects of TSLP on
non-haematopoietic cells such as fibrocytes64 (Fig. 2),
synergistic interactions of TSLP with epithelial-
derived cytokines IL-25 and IL-33 and a regulation of
TSLP expression and its function will all be critically
needed to uncover how TSLP involves in a particular
allergic disease and in the atopic march. All the ef-
forts will facilitate further development of therapeutic
measures for human allergic diseases.
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